ATHE logo

ATHE Cash From Operations

Annual CFO

-$8.26 M
+$5.22 M+38.70%

June 1, 2024

Summary

Performance

1-Year Change

+38.7%

3-Year Change

+36.12%

5-Year Change

+17.21%

15-Year Change

-86.89%

ATHE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.83%
ATHE annual cash flow from operations is higher than 63.83% of companies in Healthcare sector

High & Low

All-time High

-$1.97 M

3-Year Low

-$13.48 M

Earnings dates

Last Annual Earnings Report Date

Jun 1, 2024
ATHE previous annual earnings announcement was published on Jun 1, 2024

Next Annual Earnings Report Date

N/A
ATHE next annual earnings announcement has not yet been scheduled

OtherATHEcash flowmetrics:

Annual CFI

-$3800.00
ATHE annual cash flow from investing activities is -$3800.00

Annual CFF

$6.04 M
ATHE annual cash flow from financing activities is $6.04 million

Annual FCF

-$8.27 M
ATHE annual free cash flow is -$8.27 million

Annual CAPEX

-
ATHE annual capital expenditures value is unknown

Quarterly CFO

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ATHE Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.77 M
ATHE quarterly cash flow from operations is currently at an all-time high

3-Year Low

-$13.48 M
ATHE quarterly cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
ATHE previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
ATHE next earnings announcement has not yet been scheduled

OtherATHEcash flowmetrics:

Quarterly CFI

-$500.00
ATHE quarterly cash flow from investing activities is -$500.00

Quarterly CFF

-$9600.00
ATHE quarterly cash flow from financing activities is -$9600.00

Quarterly FCF

-
ATHE quarterly free cash flow value is unknown

Quarterly CAPEX

-
ATHE quarterly capital expenditures value is unknown

TTM CFO

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ATHE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.77 M
ATHE TTM cash flow from operations is currently at an all-time high

3-Year Low

-$20.00 M
ATHE TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
ATHE previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
ATHE next earnings announcement has not yet been scheduled

OtherATHEcash flowmetrics:

TTM CFI

-$500.00
ATHE TTM cash flow from investing activities is -$500.00

TTM CFF

-$9600.00
ATHE TTM cash flow from financing activities is -$9600.00

TTM FCF

-
ATHE TTM free cash flow value is unknown

TTM CAPEX

-
ATHE TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ATHE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.7%--
3 y3 years+36.1%--
5 y5 years+17.2%--

ATHE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+38.7%
5 y5-year-30.6%+38.7%
alltimeall time-318.9%+38.7%

Alterity Therapeutics Limited Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2024
-$8.26 M(-38.7%)
-
-
Jun 2023
-$13.48 M(+50.7%)
-$13.48 M(+106.7%)
-$20.00 M(+29.3%)
Dec 2022
-
-$6.52 M(-27.1%)
-$15.47 M(+1.3%)
Jun 2022
-$8.95 M(-30.8%)
-$8.95 M(+41.6%)
-$15.26 M(+141.6%)
Dec 2021
-
-$6.32 M(+257.4%)
-$6.32 M(+257.4%)
Jun 2021
-$12.94 M(+104.4%)
-
-
Jun 2020
-$6.33 M(-36.6%)
-
-
Dec 2019
-
-$1.77 M(-66.7%)
-$1.77 M(-66.7%)
Jun 2019
-$9.98 M(+106.5%)
-
-
Jun 2018
-$4.83 M(+9.3%)
-
-
Jun 2017
-$4.42 M(-18.1%)
-
-
Jun 2016
-$5.40 M(-40.6%)
-
-
Dec 2015
-
-$5.31 M
-$5.31 M
DateAnnualQuarterlyTTM
Jun 2015
-$9.10 M(-26.8%)
-
-
Jun 2014
-$12.43 M(+52.2%)
-
-
Jun 2013
-$8.17 M(+15.6%)
-
-
Jun 2012
-$7.06 M(+57.3%)
-
-
Jun 2011
-$4.49 M(+8.1%)
-
-
Jun 2010
-$4.15 M(-20.5%)
-
-
Jun 2009
-$5.22 M(-38.0%)
-
-
Jun 2008
-$8.42 M(+16.4%)
-
-
Jun 2007
-$7.23 M(-17.0%)
-
-
Jun 2006
-$8.71 M(+1.7%)
-
-
Jun 2005
-$8.57 M(+125.8%)
-
-
Jun 2004
-$3.79 M(+81.3%)
-
-
Jun 2003
-$2.09 M(+6.1%)
-
-
Jun 2002
-$1.97 M
-
-

FAQ

  • What is Alterity Therapeutics Limited annual cash flow from operations?
  • What is the all time high annual CFO for Alterity Therapeutics Limited?
  • What is Alterity Therapeutics Limited annual CFO year-on-year change?
  • What is the all time high quarterly CFO for Alterity Therapeutics Limited?
  • What is the all time high TTM CFO for Alterity Therapeutics Limited?

What is Alterity Therapeutics Limited annual cash flow from operations?

The current annual CFO of ATHE is -$8.26 M

What is the all time high annual CFO for Alterity Therapeutics Limited?

Alterity Therapeutics Limited all-time high annual cash flow from operations is -$1.97 M

What is Alterity Therapeutics Limited annual CFO year-on-year change?

Over the past year, ATHE annual cash flow from operations has changed by +$5.22 M (+38.70%)

What is the all time high quarterly CFO for Alterity Therapeutics Limited?

Alterity Therapeutics Limited all-time high quarterly cash flow from operations is -$1.77 M

What is the all time high TTM CFO for Alterity Therapeutics Limited?

Alterity Therapeutics Limited all-time high TTM cash flow from operations is -$1.77 M